SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-May-24 8:30 AM View: | Hemispherx Biopharma, Inc. (AIM) | 06-May-24 | Private Purchase | 30,865 | $0.41 | $12,500.30 | 17% 181.72K to 212.58K | |
18-Mar-24 3:01 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Mar-24 | Private Purchase | 37,879 | $0.33 | $12,500.10 | 26% 143.84K to 181.72K | |
04-Jan-23 7:30 AM View: | Hemispherx Biopharma, Inc. (AIM) | 03-Jan-23 | Private Purchase | 80,646 | $0.31 | $25,000.30 | 128% 63.19K to 143.84K | |
26-Apr-22 8:42 AM View: | Hemispherx Biopharma, Inc. (AIM) | 25-Apr-22 | Grant | 4,902 | $1.02 | $5,000.04 | 8% 58.29K to 63.19K | (11%) |
02-Jan-20 11:07 AM View: | Hemispherx Biopharma, Inc. (AIM) | 31-Dec-19 | Grant | 6,879 | $0.53 | $3,645.87 | 13% 51.41K to 58.29K | 104% |
16-Dec-19 9:40 AM View: | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Grant | 8,381 | $0.44 | $3,645.74 | 19% 43.03K to 51.41K | 148% |
02-Dec-19 12:09 PM View: | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Grant | 9,115 | $0.40 | $3,646.00 | 27% 33.91K to 43.03K | 200% |
18-Nov-19 2:51 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Grant | 7,752 | $0.47 | $3,643.44 | 30% 26.16K to 33.91K | 194% |
31-Oct-19 2:16 PM View: | Hemispherx Biopharma, Inc. (AIM) | 31-Oct-19 | Grant | 7,297 | $0.50 | $3,648.50 | 39% 18.87K to 26.16K | 140% |
17-Oct-19 4:42 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Oct-19 | Grant | 6,286 | $0.58 | $3,645.88 | 50% 12.58K to 18.87K | 128% |
25-Jun-19 11:04 AM View: | Hemispherx Biopharma, Inc. (AIM) | 21-Jun-19 | Market Purchase | 8,695 | $4.03 | $35,040.90 | 223% 3.9K to 12.59K | (71%) |
17-Jun-19 3:53 PM View: | Hemispherx Biopharma, Inc. (AIM) | 08-May-19 | Conversion | 63,000 | -- | -- | 58% 108.37K to 171.37K | |
17-Jun-19 3:53 PM View: | Hemispherx Biopharma, Inc. (AIM) | 18-Mar-19 | Conversion | 90,000 | -- | -- | 490% 18.37K to 108.37K | |
13-Mar-19 11:27 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Feb-19 | Exercise (in-the money or at-the-money) | 90,018 | -- | -- | 100% 0 to 90.02K | |
29-Nov-18 11:05 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Nov-18 | Grant | 2,500 | -- | -- | 16% 15.87K to 18.37K | |
03-May-17 12:50 PM View: | Hemispherx Biopharma, Inc. (AIM) | 02-May-17 | Market Purchase | 15,873 | $0.63 | $9,999.99 | 100% 0 to 15.87K | (96%) |